2012
DOI: 10.3111/13696998.2011.649326 View full text |Buy / Rent full text
|
|

Abstract: This study of 19,422 patients with cancer receiving chemotherapy and 159,758 patients with pre-dialysis CKD reported ESA dose ratios ranging from 230:1-257:1 (units EPO: mcg DARB) and associated cost premiums of 27-42% for DARB.

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals